全文获取类型
收费全文 | 49044篇 |
免费 | 2969篇 |
国内免费 | 240篇 |
专业分类
耳鼻咽喉 | 500篇 |
儿科学 | 921篇 |
妇产科学 | 626篇 |
基础医学 | 6386篇 |
口腔科学 | 1080篇 |
临床医学 | 5154篇 |
内科学 | 10803篇 |
皮肤病学 | 986篇 |
神经病学 | 5625篇 |
特种医学 | 2497篇 |
外科学 | 8222篇 |
综合类 | 295篇 |
一般理论 | 13篇 |
预防医学 | 2252篇 |
眼科学 | 643篇 |
药学 | 2932篇 |
中国医学 | 69篇 |
肿瘤学 | 3249篇 |
出版年
2023年 | 431篇 |
2022年 | 689篇 |
2021年 | 1411篇 |
2020年 | 838篇 |
2019年 | 1268篇 |
2018年 | 1432篇 |
2017年 | 1123篇 |
2016年 | 1342篇 |
2015年 | 1553篇 |
2014年 | 1963篇 |
2013年 | 2425篇 |
2012年 | 3893篇 |
2011年 | 3920篇 |
2010年 | 2329篇 |
2009年 | 2099篇 |
2008年 | 3345篇 |
2007年 | 3431篇 |
2006年 | 3164篇 |
2005年 | 3116篇 |
2004年 | 2757篇 |
2003年 | 2637篇 |
2002年 | 2375篇 |
2001年 | 435篇 |
2000年 | 333篇 |
1999年 | 396篇 |
1998年 | 477篇 |
1997年 | 362篇 |
1996年 | 286篇 |
1995年 | 221篇 |
1994年 | 219篇 |
1993年 | 164篇 |
1992年 | 141篇 |
1991年 | 132篇 |
1990年 | 97篇 |
1989年 | 89篇 |
1988年 | 93篇 |
1987年 | 60篇 |
1986年 | 72篇 |
1985年 | 69篇 |
1984年 | 102篇 |
1983年 | 80篇 |
1982年 | 75篇 |
1981年 | 57篇 |
1980年 | 55篇 |
1979年 | 48篇 |
1978年 | 47篇 |
1977年 | 50篇 |
1976年 | 46篇 |
1975年 | 47篇 |
1974年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Nishanth Parameswaran Oriol Mitj Christian Bottomley Cynthia Kwakye Wendy Houinei Allan Pillay Damien Danavall Kai-Hua Chi Ronald C. Ballard Anthony W. Solomon Cheng Y. Chen Sibauk V. Bieb Yaw Adu-Sarkodie David C. W. Mabey Kingsley Asiedu Michael Marks Diana L. Martin 《Journal of clinical microbiology》2021,59(5)
993.
994.
995.
Pearl Pugh Pippa Hemingway Martin Christian Gina Higginbottom 《Patient education and counseling》2021,104(4):844-857
BackgroundEarly dietary change can provide vital medical benefits supporting childhood chronic disease self-management.ObjectiveTo explore factors influencing the initiation of early dietary change in the management of childhood chronic disease, as described by children, parents’, and other stakeholders, to inform practice change in early paediatric service delivery.MethodsThis systematic review crossed seven databases from 2000-2018 to identify empirical research (qualitative, quantitative, and mixed-method designs), including grey literature. Methodological quality was appraised using validated scoring systems.ResultsSix studies met our criteria for inclusion in the review. Four themes of early dietary change emerged from these studies: (1) the role of education; (2) parents/caregivers’ roles; (3) the role of self-management, and the (4) identification of enablers and barriers to dietary change.ConclusionObtaining the perspectives of children, parents’ and other stakeholders’ on factors influencing early dietary change is key to the self-management of childhood chronic disease.Practice implicationsEarly dietary change provides an essential resource in the self-management of many chronic diseases. In collaboration, children, parents’ and healthcare professionals recognise the value of regular, engaging education, supported by workshops to empower and upskill, enabling change in everyday dietary habits, while using enablers and recognising challenges. 相似文献
996.
Christian Curcio Robert Cimera Ruth Aryeequaye Mamta Rao Nicola Fabbri Yanming Zhang Meera Hameed 《Genes, chromosomes & cancer》2021,60(1):43-48
Evolution of poorly differentiated chordoma from conventional chordoma has not been previously reported. We encountered a case of a poorly differentiated chordoma with evidence of whole‐genome doubling arising from a SMARCB1‐deficient conventional chordoma. The tumor presented as a destructive sacral mass in a 43‐year‐old man and was comprised of a highly cellular poorly differentiated chordoma with small, morphologically distinct nodules of conventional chordoma accounting for <5% of the total tumor volume. Immunohistochemistry (IHC) revealed both components were strongly reactive for brachyury and lacked normal staining for INI1. Single nucleotide polymorphism (SNP) array analysis identified multiple genomic imbalances in the conventional component, including deletions of 1p, 3p, and 22q (involving SMARCB1) and loss of chromosomes 5 and 15, while the poorly differentiated component exhibited the same aberrations at a more profound level with additional loss of chromosome 4, low level focal deletion of 17p (involving TP53), and tetraploidy. Homozygous deletion of SMARCB1 was present in both components. Fluorescence in situ hybridization (FISH) analysis confirmed the relevant deletions in both components as well as genome doubling in the poorly differentiated tumor. This case suggests that SMARCB1 loss is an early event in rare conventional chordomas that could potentially evolve into poorly differentiated chordoma through additional genomic aberrations such as genome doubling. Further studies with additional patients will be needed to determine if genome doubling is a consistent pathway for evolution of poorly differentiated chordoma. 相似文献
997.
998.
999.
Yan Xu Zheng Xiang Mohammed Alnaggar Lonce Kouakanou Jiawei Li Junyi He Jiashuang Yang Yi Hu Yan Chen Li Lin Jianlei Hao Jingxia Li Jibing Chen Man Li Qingling Wu Christian Peters Qinghua Zhou Jianshuang Li Yingqing Liang Xiaohua Wang Baohui Han Meili Ma Dieter Kabelitz Kecheng Xu Wenwei Tu Yangzhe Wu Zhinan Yin 《Cellular & molecular immunology》2021,18(2):427
Vγ9Vδ2 T cells are promising candidates for cellular tumor immunotherapy. Due to their HLA-independent mode of action, allogeneic Vγ9Vδ2 T cells can be considered for clinical application. To apply allogeneic Vγ9Vδ2 T cells in adoptive immunotherapy, the methodology used to obtain adequate cell numbers with optimal effector function in vitro needs to be optimized, and clinical safety and efficacy also need to be proven. Therefore, we developed a novel formula to improve the expansion of peripheral γδ T cells from healthy donors. Then, we used a humanized mouse model to validate the therapeutic efficacy of expanded γδ T cells in vivo; furthermore, the expanded γδ T cells were adoptively transferred into late-stage liver and lung cancer patients. We found that the expanded cells possessed significantly improved immune effector functions, including proliferation, differentiation, and cancer cell killing, both in vitro and in the humanized mouse model. Furthermore, a phase I clinical trial in 132 late-stage cancer patients with a total of 414 cell infusions unequivocally validated the clinical safety of allogeneic Vγ9Vδ2 T cells. Among these 132 patients, 8 liver cancer patients and 10 lung cancer patients who received ≥5 cell infusions showed greatly prolonged survival, which preliminarily verified the efficacy of allogeneic Vγ9Vδ2 T-cell therapy. Our clinical studies underscore the safety and efficacy of allogeneic Vγ9Vδ2 T-cell immunotherapy, which will inspire further clinical investigations and eventually benefit cancer patients. 相似文献
1000.
Stefania Clemente Maria Daniela Falco Elisabetta Cagni Cinzia Talamonti Mafalda Boccia Eva Gino Elena Lorenzini Federica Rosica Serenella Russo Alessandro Alparone Daniele Zefiro Christian Fiandra 《The British journal of radiology》2021,94(1119)
Objectives:This multicentric study was carried out to investigate the impact of small field output factors (OFs) inaccuracies on the calculated dose in volumetric arctherapy (VMAT) radiosurgery brain plans.Methods:Nine centres, realised the same five VMAT plans with common planning rules and their specific clinical equipment Linac/treatment planning system commissioned with their OFs measured values (OFbaseline). In order to simulate OFs errors, two new OFs sets were generated for each centre by changing only the OFs values of the smallest field sizes (from 3.2 × 3.2 cm2 to 1 × 1 cm2) with well-defined amounts (positive and negative). Consequently, two virtual machines for each centre were recommissioned using the new OFs and the percentage dose differences ΔD (%) between the baseline plans and the same plans recalculated using the incremented (OFup) and decremented (OFdown) values were evaluated. The ΔD (%) were analysed in terms of planning target volume (PTV) coverage and organs at risk (OARs) sparing at selected dose/volume points.Results:The plans recalculated with OFdown sets resulted in higher variation of doses than baseline within 1.6 and 3.4% to PTVs and OARs respectively; while the plans with OFup sets resulted in lower variation within 1.3% to both PTVs and OARs. Our analysis highlights that OFs variations affect calculated dose depending on the algorithm and on the delivery mode (field jaw/MLC‐defined). The Monte Carlo (MC) algorithm resulted significantly more sensitive to OFs variations than all of the other algorithms.Conclusion:The aim of our study was to evaluate how small fields OFs inaccuracies can affect the dose calculation in VMAT brain radiosurgery treatments plans. It was observed that simulated OFs errors, return dosimetric calculation accuracies within the 3% between concurrent plans analysed in terms of percentage dose differences at selected dose/volume points of the PTV coverage and OARs sparing.Advances in knowledge:First multicentre study involving different Planning/Linacs about undetectable errors in commissioning output factor for small fields. 相似文献